An Interview on the NRG-CC014 "PREEMPT" Study episode artwork

EPISODE · Jul 31, 2025 · 24 MIN

An Interview on the NRG-CC014 "PREEMPT" Study

from The NRG Oncology Podcast · host NRG Oncology

We interview Dr. Erin Gillespie, PI of the NRG-CC014 "PREEMPT" study comparing radiation therapy to usual therapy for patients with high-risk bone metastases that are not causing pain.

We interview Dr. Erin Gillespie, PI of the NRG-CC014 "PREEMPT" study comparing radiation therapy to usual therapy for patients with high-risk bone metastases that are not causing pain.

NOW PLAYING

An Interview on the NRG-CC014 "PREEMPT" Study

0:00 24:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The NRG Oncology Podcast?

This episode is 24 minutes long.

When was this The NRG Oncology Podcast episode published?

This episode was published on July 31, 2025.

What is this episode about?

We interview Dr. Erin Gillespie, PI of the NRG-CC014 "PREEMPT" study comparing radiation therapy to usual therapy for patients with high-risk bone metastases that are not causing pain.

Can I download this The NRG Oncology Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!